{"parse":{"title":"Medication package insert","pageid":6077451,"revid":855883421,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Patient_Package_Insert_for_Oral_Contraceptives_(FDA_079)_(8249451687).jpg\" class=\"image\"><img alt=\"An oblong blue container holding 28 yellow pills, with a small, folded paper note standing in front of it\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg/220px-Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg\" width=\"220\" height=\"165\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg/330px-Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d1/Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg/440px-Patient_Package_Insert_for_Oral_Contraceptives_%28FDA_079%29_%288249451687%29.jpg 2x\" data-file-width=\"7200\" data-file-height=\"5400\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Patient_Package_Insert_for_Oral_Contraceptives_(FDA_079)_(8249451687).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>A package insert from 1970, with <a href=\"/wiki/Ovrette\" class=\"mw-redirect\" title=\"Ovrette\">Ovrette</a> brand contraception pills</div></div></div>\n<p>A <b>package insert</b> is a document included in the <a href=\"/wiki/Drug_packaging\" title=\"Drug packaging\">package</a> of a <a href=\"/wiki/Medication\" title=\"Medication\">medication</a> that provides information about that drug and its use.  For <a href=\"/wiki/Prescription_medication\" class=\"mw-redirect\" title=\"Prescription medication\">prescription medications</a>, the insert is <a href=\"/wiki/Technical_writing\" title=\"Technical writing\">technical</a>, and provides information for <a href=\"/wiki/Health_professional\" title=\"Health professional\">medical professionals</a> about how to prescribe the drug. Package inserts for prescription drugs often include a separate document called a \"patient package insert\" with information written in <a href=\"/wiki/Plain_English\" title=\"Plain English\">plain language</a> intended for the <a href=\"/wiki/End-user\" class=\"mw-redirect\" title=\"End-user\">end-user</a> -- the person who will take the drug or give the drug to another person, for example a minor.  Inserts for <a href=\"/wiki/Over-the-counter_medication\" class=\"mw-redirect\" title=\"Over-the-counter medication\">over-the-counter medications</a> are also written plainly.<sup id=\"cite_ref-Nathan_1-0\" class=\"reference\"><a href=\"#cite_note-Nathan-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p><p>In the US the document is called \"prescribing information\" or the \"package insert\" (PI) and layperson's document is called the \"patient package insert\" (PPI).<sup id=\"cite_ref-Nathan_1-1\" class=\"reference\"><a href=\"#cite_note-Nathan-1\">&#91;1&#93;</a></sup>  In Europe the technical document is called the \"<b>summary of product characteristics</b>\" and the document for end-users is called the \"package leaflet\".<sup id=\"cite_ref-EMA_3-0\" class=\"reference\"><a href=\"#cite_note-EMA-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Responsible_agencies\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Responsible agencies</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Sections_of_a_package_insert\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Sections of a package insert</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Other_uses_and_initiatives\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Other uses and initiatives</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Responsible_agencies\">Responsible agencies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=1\" title=\"Edit section: Responsible agencies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Each country or region has their own regulatory body.  \n</p><p>In the European Union, the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> has jurisdiction and the relevant documents are called the  \"summary of product characteristics\" (SPC or SmPC) and the document for end-users is called the \"package leaflet\". The SPC is not intended to give general advice about treatment of a condition but does state how the product is to be used for a specific treatment. It forms the basis of information for health professionals to know how to use the specific product safely and effectively. The package leaflet supplied with the product is aimed at end-users.<sup id=\"cite_ref-EMA_3-1\" class=\"reference\"><a href=\"#cite_note-EMA-3\">&#91;3&#93;</a></sup>\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Drug_Package_Insert_(FDA_115)_(8206409270).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg/220px-Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg\" width=\"220\" height=\"240\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg/330px-Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg/440px-Drug_Package_Insert_%28FDA_115%29_%288206409270%29.jpg 2x\" data-file-width=\"5400\" data-file-height=\"5899\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Drug_Package_Insert_(FDA_115)_(8206409270).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>cartoon depicting the package insert as overly long and complicated</div></div></div>\n<p>In the United States, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) determines the requirements for patient package inserts.  In the United States, the FDA will occasionally issue revisions to previously approved package inserts, in much the same way as an auto manufacturer will issue <a href=\"/wiki/Product_recall\" title=\"Product recall\">recalls</a> upon discovering a problem with a certain car.  The list of 1997 drug labelling changes can be found on the FDA's website, <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/medwatch/safety/1997/dec97.htm\">here</a>. The first patient package insert required by the FDA was in 1968, mandating that <a href=\"/wiki/Isoproterenol\" class=\"mw-redirect\" title=\"Isoproterenol\">isoproterenol</a> inhalation medication must contain a short warning that excessive use could cause breathing difficulties.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"This claim needs references to reliable secondary sources. (August 2018)\">non-primary source needed</span></a></i>&#93;</sup>  The second patient package insert required by the FDA was in 1970, mandating that <a href=\"/wiki/Combined_oral_contraceptive_pill\" title=\"Combined oral contraceptive pill\">combined oral contraceptive pills</a> must contain information for the patient about specific risks and benefits.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"This claim needs references to reliable secondary sources. (August 2018)\">non-primary source needed</span></a></i>&#93;</sup>  The patient package insert issue was revisited in 1980 and in 1995 without conclusive action being taken.<a rel=\"nofollow\" class=\"external autonumber\" href=\"https://web.archive.org/web/20060905155817/http://leda.law.harvard.edu/leda/data/85/bschuman.rtf\">[1]</a> Finally, in January 2006, the FDA released a major revision to the patient package insert guidelines, the first in 25 years.<a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.fda.gov/bbs/topics/NEWS/2005/NEW01272.html\">[2]</a> The new requirements include a section called Highlights which summarizes the most important information about benefits and risks; a Table of Contents for easy reference; the date of initial product approval; and a <a href=\"/wiki/Toll-free_number\" class=\"mw-redirect\" title=\"Toll-free number\">toll-free number</a> and Internet address to encourage more widespread reporting of information regarding suspected adverse events.\n</p><p>Other national or international organizations that regulate medical information include the <a href=\"/wiki/Ministry_of_Health,_Labour_and_Welfare_(Japan)\" class=\"mw-redirect\" title=\"Ministry of Health, Labour and Welfare (Japan)\">Japanese Ministry of Health, Labour, and Welfare</a> (MHLW). Other country-specific agencies, especially in the case of EU (<a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>) countries and candidates, plus countries of South America and many in Asia and the Far East, rely heavily on the work of these three primary regulators.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (August 2018)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Sections_of_a_package_insert\">Sections of a package insert</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=2\" title=\"Edit section: Sections of a package insert\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Package_insert\" class=\"mw-redirect\" title=\"Package insert\">Package inserts</a> follow a standard format for every medication and include the same types of information.  Different manufacturers may have different titles for their sections, however, to make them easier for the average person to read and comprehend\u2014for example, instead of \"Contraindications\" the section may be headed, \"Who should not take this medication?\" \n</p><p>The first thing listed is usually the brand name and generic name of the product.  The other sections are as follows:\n</p>\n<ul><li><a href=\"/wiki/Clinical_pharmacology\" title=\"Clinical pharmacology\">Clinical pharmacology</a> - tells how the medicine works in the body, how it is absorbed and eliminated, and what its effects are likely to be at various concentrations.  May also contain results of various <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> (studies) and/or explanations of the medication's effect on various populations (e.g. children, women, etc.).</li>\n<li>Indications and usage - uses (indications) for which the drug has been FDA-approved (e.g. migraines, seizures, high blood pressure). Physicians legally can and often do prescribe medicines for purposes not listed in this section (so-called \"<a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a>\").</li>\n<li><a href=\"/wiki/Contraindications\" class=\"mw-redirect\" title=\"Contraindications\">Contraindications</a> - lists situations in which the medication should <i>not</i> be used, for example in patients with other medical conditions such as kidney problems or allergies</li>\n<li>Warnings - covers possible serious <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">side effects</a> that may occur</li>\n<li>Precautions - explains how to use the medication safely including physical impairments and drug interactions; for example \"Do not drink alcohol while taking this medication\" or \"Do not take this medication if you are currently taking <a href=\"/wiki/Monoamine_oxidase_inhibitor\" title=\"Monoamine oxidase inhibitor\">MAOI inhibitors</a>\"</li>\n<li>Adverse reactions - lists <i>all</i> side effects observed in all studies of the drug (as opposed to just the dangerous side effects which are separately listed in \"Warnings\" section)</li>\n<li>Drug abuse and dependence - provides information regarding whether prolonged use of the medication can cause <a href=\"/wiki/Physical_dependence\" title=\"Physical dependence\">physical dependence</a> (only included if applicable)</li>\n<li>Overdosage - gives the results of an <a href=\"/wiki/Overdose\" class=\"mw-redirect\" title=\"Overdose\">overdose</a> and provides recommended action in such cases</li>\n<li>Dosage and administration - gives recommended dosage(s); may list more than one for different conditions or different patients (e.g., lower dosages for children)</li>\n<li>How supplied - explains in detail the physical characteristics of the medication including color, shape, markings, etc., and storage information (e.g., \"Store between 68 and 78\u00b0F \")</li></ul>\n<p><br />\n</p>\n<h2><span class=\"mw-headline\" id=\"Other_uses_and_initiatives\">Other uses and initiatives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=3\" title=\"Edit section: Other uses and initiatives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In addition to the obvious use of inclusion with medications, package inserts have been used or provided in other forms.  In the United States, the package inserts for thousands of prescription medicines are available at the <a href=\"/wiki/DailyMed\" title=\"DailyMed\">DailyMed</a> website, provided by the National Library of Medicine: <a rel=\"nofollow\" class=\"external free\" href=\"http://dailymed.nlm.nih.gov\">http://dailymed.nlm.nih.gov</a> South Africa has taken the initiative of making all package inserts available electronically via the internet, listed by trade name, <a href=\"/wiki/International_Nonproprietary_Name\" class=\"mw-redirect\" title=\"International Nonproprietary Name\">generic name</a>, and classification, and Canada is working on a similar capability. The UK-based <a rel=\"nofollow\" class=\"external text\" href=\"http://emc.medicines.org.uk\">electronic Medicines Compendium</a> provides freely available online access to both Patient Information Leaflets (intended for consumers) and <a href=\"/wiki/Summary_of_Product_Characteristics\" class=\"mw-redirect\" title=\"Summary of Product Characteristics\">Summary of Product Characteristics</a> (aimed at healthcare professionals) for products available in the UK.\n</p><p>Patient information is, understandably, usually generated initially in the native language of the country where the product is being developed.  This leads to inconsistency in format, terminology, tone, and content.  PILLS (Patient Information Language Localisation System) is a one-year effort by the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a> to produce a prototype tool which will support the creation of various kinds of medical documentation simultaneously in multiple languages, by storing the information in a database and allowing a variety of forms and languages of output.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Patient_education\" title=\"Patient education\">Patient education</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Nathan-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Nathan_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Nathan_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nathan, Joseph P.; Vider, Etty (2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.uspharmacist.com/article/the-package-insert\">\"The Package Insert\"</a>. <i>US Pharm</i>. <b>40</b> (5): 8\u201310.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=US+Pharm.&amp;rft.atitle=The+Package+Insert&amp;rft.volume=40&amp;rft.issue=5&amp;rft.pages=8-10.&amp;rft.date=2015&amp;rft.aulast=Nathan&amp;rft.aufirst=Joseph+P.&amp;rft.au=Vider%2C+Etty&amp;rft_id=https%3A%2F%2Fwww.uspharmacist.com%2Farticle%2Fthe-package-insert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedication+package+insert\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Nadine Vanlaer (August 31, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.packaging-gateway.com/features/feature755/\">\"Drug Package Inserts: the Letter of the Law - Packaging Gateway\"</a>. <i>Packaging Gateway</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Packaging+Gateway&amp;rft.atitle=Drug+Package+Inserts%3A+the+Letter+of+the+Law+-+Packaging+Gateway&amp;rft.date=2006-08-31&amp;rft.au=Nadine+Vanlaer&amp;rft_id=https%3A%2F%2Fwww.packaging-gateway.com%2Ffeatures%2Ffeature755%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedication+package+insert\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-EMA-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-EMA_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-EMA_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000199.jsp&amp;mid=WC0b01ac0580022bb3\">\"Marketing authorisation - Product-information requirements\"</a>. European Medicines Agency<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">18 August</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Marketing+authorisation+-+Product-information+requirements&amp;rft.pub=European+Medicines+Agency&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fregulation%2Fgeneral%2Fgeneral_content_000199.jsp%26mid%3DWC0b01ac0580022bb3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedication+package+insert\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\">33 Fed. Reg. 8812 (1968) (codified at 21 C.F.R. \u00a7201.305)</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">33 Fed. Reg. 9001 (1970) (codified at 21 C.F.R. \u00a7310.510)</span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medication_package_insert&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://home.intekom.com/pharm/\">South African Electronic Package Inserts</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000357.jsp&amp;mid=WC0b01ac05806361e1\">EMA guidance on preparing SmPC</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicines.org.uk\">Electronic Medicines Compendium</a>, which published SmPCs and Package Leaflets in the UK</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1223\nCached time: 20180912133430\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.144 seconds\nReal time usage: 0.189 seconds\nPreprocessor visited node count: 604/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 11047/2097152 bytes\nTemplate argument size: 1833/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4104/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.065/10.000 seconds\nLua memory usage: 2.18 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  147.811      1 -total\n 48.82%   72.162      2 Template:Primary-inline\n 42.12%   62.260      1 Template:Reflist\n 41.26%   60.990      3 Template:Fix\n 22.98%   33.969      1 Template:Cite_journal\n 21.02%   31.075      4 Template:Category_handler\n 17.71%   26.173      3 Template:Delink\n  8.37%   12.367      1 Template:Cn\n  4.18%    6.185      1 Template:Cite_web\n  3.95%    5.837      1 Template:Cite_news\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:6077451-0!canonical and timestamp 20180912133430 and revision id 855883421\n -->\n</div>"},"langlinks":[{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Bijsluiter","langname":"Dutch","autonym":"Nederlands","*":"Bijsluiter"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E6%B7%BB%E4%BB%98%E6%96%87%E6%9B%B8","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u6dfb\u4ed8\u6587\u66f8"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Bula_(medicamento)","langname":"Portuguese","autonym":"portugu\u00eas","*":"Bula (medicamento)"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%98%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D0%B8%D1%8F_%D0%BF%D0%BE_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D0%B5%D0%BD%D0%B8%D1%8E_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0418\u043d\u0441\u0442\u0440\u0443\u043a\u0446\u0438\u044f \u043f\u043e \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044e \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430"}],"categories":[{"sortkey":"","hidden":"","*":"All_pages_needing_factual_verification"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_factual_verification_from_August_2018"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_August_2018"},{"sortkey":"","*":"Health_informatics"},{"sortkey":"","*":"Pharmaceutical_industry"},{"sortkey":"","*":"Packaging"},{"sortkey":"","*":"Labels"}],"links":[{"ns":14,"exists":"","*":"Category:Wikipedia articles needing factual verification from August 2018"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from August 2018"},{"ns":0,"exists":"","*":"Package insert"},{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Clinical pharmacology"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Combined oral contraceptive pill"},{"ns":0,"exists":"","*":"Contraindications"},{"ns":0,"exists":"","*":"DailyMed"},{"ns":0,"exists":"","*":"Drug packaging"},{"ns":0,"exists":"","*":"End-user"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Health professional"},{"ns":0,"exists":"","*":"International Nonproprietary Name"},{"ns":0,"exists":"","*":"Isoproterenol"},{"ns":0,"exists":"","*":"Medication"},{"ns":0,"exists":"","*":"Ministry of Health, Labour and Welfare (Japan)"},{"ns":0,"exists":"","*":"Monoamine oxidase inhibitor"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Over-the-counter medication"},{"ns":0,"exists":"","*":"Overdose"},{"ns":0,"exists":"","*":"Ovrette"},{"ns":0,"exists":"","*":"Patient education"},{"ns":0,"exists":"","*":"Physical dependence"},{"ns":0,"exists":"","*":"Plain English"},{"ns":0,"exists":"","*":"Prescription medication"},{"ns":0,"exists":"","*":"Product recall"},{"ns":0,"exists":"","*":"Summary of Product Characteristics"},{"ns":0,"exists":"","*":"Technical writing"},{"ns":0,"exists":"","*":"Toll-free number"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:No original research"}],"templates":[{"ns":10,"exists":"","*":"Template:Primary-inline"},{"ns":10,"exists":"","*":"Template:Primary source inline"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Cn"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Patient_Package_Insert_for_Oral_Contraceptives_(FDA_079)_(8249451687).jpg","Drug_Package_Insert_(FDA_115)_(8206409270).jpg"],"externallinks":["https://www.uspharmacist.com/article/the-package-insert","https://www.packaging-gateway.com/features/feature755/","http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000199.jsp&mid=WC0b01ac0580022bb3","http://www.fda.gov/medwatch/safety/1997/dec97.htm","https://web.archive.org/web/20060905155817/http://leda.law.harvard.edu/leda/data/85/bschuman.rtf","http://www.fda.gov/bbs/topics/NEWS/2005/NEW01272.html","http://emc.medicines.org.uk","http://home.intekom.com/pharm/","http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000357.jsp&mid=WC0b01ac05806361e1","http://www.medicines.org.uk","http://dailymed.nlm.nih.gov"],"sections":[{"toclevel":1,"level":"2","line":"Responsible agencies","number":"1","index":"1","fromtitle":"Medication_package_insert","byteoffset":2095,"anchor":"Responsible_agencies"},{"toclevel":1,"level":"2","line":"Sections of a package insert","number":"2","index":"2","fromtitle":"Medication_package_insert","byteoffset":5194,"anchor":"Sections_of_a_package_insert"},{"toclevel":1,"level":"2","line":"Other uses and initiatives","number":"3","index":"3","fromtitle":"Medication_package_insert","byteoffset":7671,"anchor":"Other_uses_and_initiatives"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Medication_package_insert","byteoffset":9131,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Medication_package_insert","byteoffset":9168,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Medication_package_insert","byteoffset":9198,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Medication package insert","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q4384594"}]}}